Richmond Pharmacology is excited to join BioJapan 2026 in Yokohama, Japan, on 07- 09 October 2026.

Connecting global leaders in biotechnology and life sciences, BioJapan is a premier platform for fostering partnerships, sharing cutting-edge research, and driving innovation across the healthcare and pharmaceutical sectors.

Representing Richmond Pharmacology

Dr Jörg Taubel, Chief Executive Officer

Stephen Wilkinson, Business Development Manager

Nobuo Ittetsu, Head of Japanese Volunteer Recruitment

Minoru Takada, Japanese Business Development Executive

We look forward to connecting with attendees to discuss Richmond’s expertise in:

Innovations in biotechnology and clinical trial design

Regulatory pathways for emerging therapies

Patient-centric approaches and recruitment strategies

Collaboration between academia, industry, and regulators

Data-driven solutions for accelerating development

Connect With Us

If you are attending BioJapan 2026 and would like to explore partnership or development opportunities email us at: 📧 fasteranswers@richmondpharmacology.com

‍

Learn more

Back to events